Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions
Anant Narayan Bhatt, Abhishek Kumar, Yogesh Rai, et al.
Life Sciences (2022) Vol. 295, pp. 120411-120411
Open Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Glycolytic interference blocks influenza A virus propagation by impairing viral polymerase-driven synthesis of genomic vRNA
Jens Kleinehr, Michael Schöfbänker, Katharina Daniel, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 7, pp. e1010986-e1010986
Open Access | Times Cited: 5
Influenza A virus-induced glycolysis facilitates virus replication by activating ROS/HIF-1α pathway
Yijia Zhang, Lifeng Chang, Xin Xin, et al.
Free Radical Biology and Medicine (2024) Vol. 225, pp. 910-924
Closed Access | Times Cited: 1
A novel property of hexokinase inhibition by Favipiravir and proposed advantages over Molnupiravir and 2 Deoxy d glucose in treating COVID-19
Prajakta Kulkarni, Sriram Padmanabhan
Biotechnology Letters (2022) Vol. 44, Iss. 7, pp. 831-843
Open Access | Times Cited: 6
Host-directed therapy with 2-deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2
Laxmikant Wali, Michael Karbiener, Scharon Chou, et al.
Journal of Virus Eradication (2022) Vol. 8, Iss. 4, pp. 100305-100305
Open Access | Times Cited: 6
A metabolic blueprint of COVID-19 and long-term vaccine efficacy
Engin Berber, Deepak Sumbria, Serkan Kökkaya
Drug Metabolism and Personalized Therapy (2022) Vol. 38, Iss. 1, pp. 15-29
Open Access | Times Cited: 5
2-Deoxy-d-Glucose: A Repurposed Drug for COVID-19 Treatment
Simran Chopra, Aditya Dahiya, Ashrit Nair, et al.
(2023), pp. 479-500
Closed Access | Times Cited: 2
Modulation of pentose phosphate pathway augments the efficacy of 2-deoxy-D-glucose in COVID-19 management
Simran Chopra, Ashrit Nair, Navneet Sharma, et al.
Elsevier eBooks (2024), pp. 69-81
Closed Access
Caspase-1/11 Controls Zika Virus Replication in Astrocytes by Regulating Glycolytic Metabolism
Ingrid Sancho de Farias, Guilherme Ribeiro, Isaú H. Noronha, et al.
Research Square (Research Square) (2024)
Closed Access
Caspase-1/11 Controls Zika Virus Replication in Astrocytes by Regulating Glycolytic Metabolism
Ingrid Sancho de Farias, Guilherme Ribeiro, Isaú H. Noronha, et al.
Research Square (Research Square) (2024)
Closed Access
Interactions of SARS-CoV-2 with Human Target Cells—A Metabolic View
Wolfgang Eisenreich, Julian Leberfing, Thomas Rudel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9977-9977
Open Access
Possible mechanisms of SARS-CoV-2-associated myocardial fibrosis: reflections in the post-pandemic era
Zhan Wang, Luwei Li, Shuai Yang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Interferon Signaling-Dependent Contribution of Glycolysis to Rubella Virus Infection
Erik Schilling, Maria Elisabeth Wald, Juliane Schulz, et al.
Pathogens (2022) Vol. 11, Iss. 5, pp. 537-537
Open Access | Times Cited: 2
Host-directed therapy with 2-Deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2
Laxmikant Wali, Michael Karbiener, Scharon Chou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Pyruvate dehydrogenase kinase 1 promotes neuronal apoptosis upon Japanese encephalitis virus infection
Surajit Chakraborty, Ellora Sen, Anirban Basu
IBRO Neuroscience Reports (2022) Vol. 13, pp. 410-419
Open Access | Times Cited: 2
"Repurposing of Heterocyclic Compounds as Anti- COVID-19 (SARS-Cov-2) Therapeutics: A Review"
Rakesh Kumar
Biomedical Journal of Scientific & Technical Research (2021) Vol. 38, Iss. 4
Open Access | Times Cited: 1
Human muscle cells sensitivity to chikungunya virus infection relies on their glycolysis activity and differentiation stage
Mathilde Jaquet, Michèle Bengue, Karen Lambert, et al.
Biochimie (2023) Vol. 218, pp. 85-95
Open Access
Amidst Cytokine Storm in Metabolic Diseases: Can 2-deoxy-D-glucose (2-DG) Cure COVID-19?
Shweta Shrivastava, Ayush Kumar, Manish Kumar Jeengar, et al.
Coronaviruses (2023) Vol. 5, Iss. 2
Closed Access
SARS-CoV-2 Nsp6 causes cardiac defects through MGA/MAX complex-mediated increased glycolysis
Junyi Zhu, Guanglei Wang, Xiaohu Huang, et al.
Research Square (Research Square) (2022)
Open Access
Glycolytic interference blocks influenza A virus propagation by impairing viral polymerase-driven synthesis of genomic vRNA
Jens Kleinehr, Daniel Kavan, Franziska Günl, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
The Mode of Therapeutic Action of 2-deoxy D-glucose: Anti- Viral or Glycolysis Blocker?
Boyli Ghosh, Sudip Roy, Jayant K. Singh
(2021)
Open Access
Previous Page - Page 2

Scroll to top